A celebratory event marking 25 years since the IRC’s launch will be held at QMUL. This will provide an opportunity to hear about the aims, ambitions and achievements of the IRC in Biomedical Materials, to develop future research collaborations at QMUL and to hear about its legacy.

The IRC pioneered innovation, development and testing of biomaterials and addressed the fundamentals of biological and clinical interfacing of materials. A key underpinning feature was the multidisciplinarity of IRC staff and students. The cross-disciplinary
interactions involved cell culture, mass transport, metrology, materials processing and characterisation. 

Find out More

During its twelve years of operation, the IRC trained over 100 PhD students, who are now working in academic, clinical, research and industrial careers worldwide, as well as some pursuing successful careers outside science. A spin-out company, ApaTech Limited, was set up to commercially exploit the synthetic bone graft replacement technology developed by academics within the IRC.

The IRC legacy at QMUL is the Institute of Bioengineering, established in 2015, a cross-faculty initiative bringing together 50 academics from the faculties of Science & Engineering and Medicine & Dentistry. The Institute provides a focus for ground-breaking research aimed at the development of new medical technologies to meet the key healthcare challenges of the 21st century.